A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors
Christian Dittrich(Kaiser-Franz-Josef-Spital), Richard Greil(Paracelsus Medical University)
Cited by 18
Related Papers
No related papers found
Powered by citation graph analysis